Bank of New York Mellon’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.7K | Sell |
79,418
-237,037
| -75% | -$73.7K | ﹤0.01% | 4083 |
|
|
2025
Q1 | $155K | Buy |
316,455
+59,178
| +23% | +$28.9K | ﹤0.01% | 3922 |
|
|
2024
Q4 | $220K | Buy |
257,277
+10,831
| +4% | +$9.27K | ﹤0.01% | 3895 |
|
|
2024
Q3 | $2.09M | Sell |
246,446
-37,347
| -13% | -$317K | ﹤0.01% | 2713 |
|
|
2024
Q2 | $1.33M | Buy |
+283,793
| New | +$1.33M | ﹤0.01% | 3030 |
|
|
2024
Q1 | – | Sell |
-26,960
| Closed | -$90.3K | – | 4151 |
|
|
2023
Q4 | $90.3K | Buy |
+26,960
| New | +$90.3K | ﹤0.01% | 4097 |
|
|
2022
Q2 | – | Sell |
-70,458
| Closed | -$149K | – | 4581 |
|
|
2022
Q1 | $149K | Buy |
70,458
+2,062
| +3% | +$4.36K | ﹤0.01% | 4321 |
|
|
2021
Q4 | $612K | Buy |
68,396
+933
| +1% | +$8.35K | ﹤0.01% | 3666 |
|
|
2021
Q3 | $1.12M | Buy |
67,463
+8,955
| +15% | +$149K | ﹤0.01% | 3323 |
|
|
2021
Q2 | $1.22M | Sell |
58,508
-1,862
| -3% | -$38.7K | ﹤0.01% | 3288 |
|
|
2021
Q1 | $1.13M | Buy |
60,370
+1,698
| +3% | +$31.8K | ﹤0.01% | 3254 |
|
|
2020
Q4 | $1.29M | Buy |
58,672
+2,911
| +5% | +$64.1K | ﹤0.01% | 3101 |
|
|
2020
Q3 | $1.16M | Sell |
55,761
-197
| -0.4% | -$4.09K | ﹤0.01% | 3034 |
|
|
2020
Q2 | $2.02M | Buy |
55,958
+26,461
| +90% | +$957K | ﹤0.01% | 2665 |
|
|
2020
Q1 | $964K | Buy |
29,497
+7,095
| +32% | +$232K | ﹤0.01% | 3008 |
|
|
2019
Q4 | $611K | Buy |
22,402
+1,780
| +9% | +$48.5K | ﹤0.01% | 3481 |
|
|
2019
Q3 | $227K | Sell |
20,622
-196
| -0.9% | -$2.16K | ﹤0.01% | 3867 |
|
|
2019
Q2 | $172K | Buy |
+20,818
| New | +$172K | ﹤0.01% | 3941 |
|